Finding 582645 (2021-001)

Material Weakness Repeat Finding
Requirement
AE
Questioned Costs
-
Year
2021
Accepted
2023-12-21
Audit: 8165
Organization: Frederick Health Inc. (NJ)

AI Summary

  • Core Issue: There is a significant internal control weakness in the review process for claims submitted for reimbursement under the HRSA COVID-19 program.
  • Impacted Requirements: The lack of documentation means there's no assurance that claims were compliant with eligibility and allowable services as per federal regulations.
  • Recommended Follow-Up: Management should create and maintain proper documentation to support internal controls, ensuring claims are reviewed correctly before submission to HRSA.

Finding Text

Section III – Federal Award Findings and Questioned Costs Finding Reference: 2021-001 Federal Program Information Federal Agency: U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) Award: Assistance Listing Number 93.461 COVID-19 - HRSA COVID-19 Claims Reimbursement for the Uninsured Program and the COVID-19 Coverage Assistance Fund Award Period: February 4, 2020 – April 5, 2022 Description: Internal control deficiency over review of claims prior to submission Type of Finding: Material Weakness in Internal Control Over Compliance Criteria or specific requirement (including statutory, regulatory or other citation) In accordance with Title 2 U.S. Code of Federal Regulations, Part 200.303, Internal controls, “Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award.” These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States or the “Internal Control Integrated Framework”, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). A. Activities Allowed or Unallowed – Activities allowed include required primary health services as described in the terms and conditions of the award for uninsured individuals, including reimbursement of payments for COVID-19 testing and testing-related items for individuals who do not have coverage through an individual or employer-sponsored plan, a federal healthcare program, or the Federal Employees Health Benefits Program at the time the services were rendered. E. Eligibility – Services must be for individuals who at the time the services were provided were uninsured as described in the terms and conditions of the award. Condition The System did not retain audit evidence of its internal controls over its review and approval of claims ensuring the patients were eligible and the services are allowable under the program’s terms and conditions prior to submission on the HRSA portal for reimbursement. Cause Management designed a process to verify that claims were in full compliance with the program’s terms and conditions, noting patients were eligible and services were allowable, prior to submission to HRSA; however, they did not retain supporting documentation to evidence that the internal review controls were appropriately designed and functioning throughout the process. Effect or potential effect The patient could have had insurance coverage at the time the service was performed or the amount submitted for reimbursement could have been partially or wholly unallowable under the program’s terms and conditions, resulting in receiving funds from the HRSA COVID-19 Uninsured Program inappropriately or not providing refunds to HRSA on a timely basis. Questioned costs None Identification of a repeat finding This is a repeat finding. Context Management did not retain evidence supporting their internal control over the process to seek reimbursement for claims submitted to the HRSA portal. Recommendation We recommend that management develop appropriate documentation to support the internal controls that would ensure claims are reviewed and complied with the program’s terms and conditions prior to submission on the HRSA portal to ensure appropriate reimbursement or that amounts required to be refunded to HRSA are analyzed on a timely basis. View of responsible officials There is no disagreement with the audit finding.

Categories

Internal Control / Segregation of Duties Allowable Costs / Cost Principles Cash Management Eligibility Material Weakness Matching / Level of Effort / Earmarking

Other Findings in this Audit

  • 6203 2021-001
    Material Weakness Repeat
  • 6204 2021-002
    Material Weakness Repeat
  • 6205 2021-003
    Material Weakness
  • 582646 2021-002
    Material Weakness Repeat
  • 582647 2021-003
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.498 Provider Relief Fund $11.92M
93.461 Covid-19 Testing for the Uninsured $2.73M
97.036 Disaster Grants - Public Assistance (presidentially Declared Disasters) $1.60M
16.575 Crime Victim Assistance $292,801
16.588 Violence Against Women Formula Grants $11,613